SGLT1: A Potential Drug Target for Cardiovascular Disease

SGLT1 and SGLT2 are the two main members of the sodium-glucose cotransporters (SGLTs), which are mainly responsible for glucose reabsorption in the body. In recent years, many large clinical trials have shown that SGLT2 inhibitors have cardiovascular protection for diabetic and non-diabetic patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Mengnan, Li, Na, Zhou, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332373/
https://www.ncbi.nlm.nih.gov/pubmed/37435096
http://dx.doi.org/10.2147/DDDT.S418321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332373/
https://www.ncbi.nlm.nih.gov/pubmed/37435096
http://dx.doi.org/10.2147/DDDT.S418321

Ejemplares similares